<DOC>
	<DOCNO>NCT00001017</DOCNO>
	<brief_summary>To compare safety effectiveness new drug , fluconazole , usual therapy , amphotericin B , prevention relapse cryptococcal meningitis ( CM ) patient AIDS successfully treat acute CM last 6 month . Cryptococcal meningitis life-threatening infectious complication AIDS . Because relapse treatment occur 50 percent case , chronic maintenance therapy intravenous ( IV ) amphotericin B usually give . However , amphotericin B always effective , toxic effect , must give intravenous route . Fluconazole antifungal agent give orally show effective cryptococcal infection animal acute CM AIDS patient . Also , side effect experienced 2000 patient volunteer give fluconazole seldom severe enough require withdrawal drug .</brief_summary>
	<brief_title>Comparison Fluconazole Amphotericin B Treatment Brain Infections Patients With AIDS</brief_title>
	<detailed_description>Cryptococcal meningitis life-threatening infectious complication AIDS . Because relapse treatment occur 50 percent case , chronic maintenance therapy intravenous ( IV ) amphotericin B usually give . However , amphotericin B always effective , toxic effect , must give intravenous route . Fluconazole antifungal agent give orally show effective cryptococcal infection animal acute CM AIDS patient . Also , side effect experienced 2000 patient volunteer give fluconazole seldom severe enough require withdrawal drug . Patients accept trial randomly assign fluconazole amphotericin B. Fluconazole give orally day amphotericin B give intravenously week . Dosages depend body weight . Medications may give amphotericin B prevent reduce discomfort associate side effect . Patients treat 12 month may continue receive antiviral therapy , radiation therapy mucocutaneous Kaposi 's sarcoma , preventive therapy Pneumocystis carinii pneumonia ( PCP ) study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Inclusion Criteria HIV infection document antibody ( ELISA two occasion ELISA Western blot confirmation ) , p24 antigen testing , recovery HIV culture . Prior Medication : Required : Minimum total dose 15 mg/kg amphotericin B ( either alone combination flucytosine ) primary therapy . End primary therapy within 6 week start maintenance therapy . Allowed : Past present antiviral therapy prophylaxis Pneumocystis carinii pneumonia ( PCP ) . Pfizer must notify patient receive ganciclovir entry . Allowed amphotericin B treat prevent side effect . Antipyretics . Hydrocortisone . Meperidine . Exclusion Criteria Coexisting Condition : Patients follow exclude : Clinical evidence acute chronic meningitis cryptococcosis . Allergy intolerance imidazole , azoles , amphotericin B . Unable take oral medication reliably . Patients follow exclude : Clinical evidence acute chronic meningitis cryptococcosis . Allergy intolerance imidazole , azoles , amphotericin B . Prior Medication : Excluded 7 day initiation primary therapy cryptococcosis : Ketoconazole . Fluconazole . Itraconazole . Miconazole . Any systemic imidazole azole . Excluded : Intrathecal amphotericin B. Coumadintype anticoagulant . Oral hypoglycemics . Barbiturates . Phenytoin . Immunostimulants . Investigational drug approve ( license ) drug investigational indication . Prior Treatment : Excluded : Lymphocyte replacement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Injections , Intravenous</keyword>
	<keyword>Cryptococcosis</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amphotericin B</keyword>
</DOC>